NAD+ Side Effects: What to Expect, Especially With IV and Injections

NAD+ is a coenzyme your body makes and uses in every cell. How you take it changes both how much reaches your bloodstream and which side effects show up. Oral NAD+ (and precursors like NMN and NR) is processed through your gut, so its side effects are digestive. IV NAD+ goes directly into circulation and produces the well-known infusion reaction; a subcutaneous injection is absorbed more gradually from under the skin, so its side effects are mostly at the injection site. Because most "NAD+ side effects" articles only cover the oral supplement, they miss the injectable routes most readers are weighing, so let's start there.

If you have looked into NAD+ IV therapy, you have probably heard about the "rush," and it is real. When NAD+ is delivered quickly, many people feel a wave of nausea, warmth or flushing, a tight or pressured feeling in the chest or abdomen, and lightheadedness. Some describe it as intense but short. Infusion clinics consistently tie it to speed: the faster the drip, the stronger the reaction, and slowing the infusion usually settles it. That account comes from clinical practice rather than trials. In the one published human pharmacokinetic study, eight healthy men received NAD+ by slow IV infusion over six hours and no adverse events were observed (Grant et al., 2019). That is why supervised NAD+ IVs are run slowly and adjusted to how you feel. Subcutaneous NAD+ is different: there is no drip to slow, and the dose is absorbed gradually from under the skin, so the infusion rush is not the typical experience. Some people report brief nausea, flushing or headache after a shot, and those reports have not been well studied.

In a supervised setting, this reaction is generally not considered dangerous. It is uncomfortable and transient, and the rate is the lever clinicians use to control it.

For oral NAD+, NMN, and NR, the side effects are mild and centered on digestion. Consumer-health coverage lists the common ones as nausea or stomach discomfort, headaches, lightheadedness, diarrhea, muscle cramps, and skin irritation (Cleveland Clinic). They are usually transient and settle as your body adjusts. Oral precursors are converted along the way, yet randomized trials show oral nicotinamide riboside raises blood NAD+ (Martens et al., 2018). Injection avoids gut breakdown, but no human trial shows it raises NAD+ inside cells more than oral precursors do, and injected NAD+ has far less human safety data behind it.

The trial data say the same thing. A 2024 systematic review of NAD supplementation pooled 10 studies and 489 participants, mostly using oral NADH and NAD+ precursors. Supplementation was well tolerated. Every study recorded some side effects, and the most common were muscle pain, nervous-system complaints, fatigue, sleep disturbance and headaches, none of which posed a serious health risk to participants (Gindri et al., 2024).*

With subcutaneous NAD+ injections, the most common local effect is what you would expect from any injectable: redness, soreness, or mild swelling at the injection site. Rotating sites, using a fresh sterile needle, and letting any alcohol dry before injecting prevents most of it.

Serious reactions to NAD+ are uncommon, but you should know the signs and act on them: a true allergic reaction (rash or hives, swelling of the face, lips, or throat, or any trouble breathing) is a medical emergency, so seek care immediately.

On dosing: NAD+ and its building blocks appear well tolerated at typical doses, but very high intakes are a different story. A review of high-dose nicotinamide (a NAD+ precursor) found that headache, dizziness, and vomiting occurred in healthy people at large oral doses, and flagged that safety data at the top of the dose range is still limited (Hwang & Song, 2020). The practical takeaway is the same one that runs through this whole article: dose and rate matter, and both belong with a prescriber rather than a guessing game.

For IV, the infusion "rush" is the shortest-lived: by clinical accounts it settles soon after the drip is slowed and does not outlast the session. Oral GI effects are usually mild and pass as your body adjusts. Injection-site redness or soreness typically fades within a day or two, as with other under-the-skin injections. No trial has measured these timelines for NAD+ specifically. Anything persistent, worsening, or allergic is a reason to contact your prescriber rather than wait it out.

For most people, physician-supervised NAD+ at appropriate doses and infusion rates is well tolerated. The infusion reaction, while unpleasant, is transient and is managed by slowing the delivery. The situations where NAD+ becomes genuinely risky are the familiar ones: unsupervised high-dose IVs pushed too fast, gray-market product of uncertain purity, and no one monitoring you. Supervised NAD+ from a licensed pharmacy reduces those risks, which is the point of doing it through a medical provider.

• Go slow on IVs. The single most effective step. A slower infusion, titrated to how you feel, prevents most of the rush.
• Start under a prescriber's guidance. The right dose and delivery for you is the difference between barely noticing anything and a rough session.
• Hydrate and eat something first. Going in well-hydrated and not on a completely empty stomach tends to make the experience smoother.
• Nail injection technique (for subcutaneous): rotate sites, sterile needle each time, let alcohol dry.
• Report anything allergic immediately. Breathing changes, swelling, or hives are never "wait and see."

The Protocol MD NAD+ protocol is physician-prescribed and delivered as a subcutaneous injectable, with the dose set by a prescriber, so you are not betting on an unsupervised drip or a gray-market vial. It is compounded by a licensed 503A pharmacy, and compounded NAD+ is not an FDA-approved drug. That means a real evaluation up front, a dose and delivery set by a prescriber, and someone accountable if a side effect shows up. Those are the safeguards that keep NAD+ on the well-tolerated end of the spectrum. See how Protocol MD's physician-prescribed NAD+ works, or read our complete NAD+ guide for the full picture. (For the upside side of the ledger, see our rundown of NAD+ benefits.)

NAD+ side effects are, for most people, mild and closely tied to form. Oral means occasional digestive upset. IV means the characteristic infusion "rush," which is uncomfortable but transient and, by clinical accounts, controlled mainly by how slowly it is given. Subcutaneous injections mostly mean injection-site soreness. Serious reactions are uncommon. As with most things in this space, the factors that actually determine your experience are appropriate dosing, a sensible infusion rate, and a physician-supervised product from a licensed pharmacy rather than an unsupervised or gray-market one.